Evidence map›Paper›PMID 34550991›Full record

ArticlePloS one2021

Right ventricular function and vasoactive peptides for early prediction of bronchopulmonary dysplasia.

Roland P Neumann, Sven M Schulzke, Christian Pohl, Sven Wellmann, Boris Metze, Ann-Katrin Burdensky, Vinzenz Boos, Payman Barikbin, Christoph Bührer, Christoph Czernik

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Roland P NeumannDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.ORCID 0000-0002-7536-5341
Sven M SchulzkeDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Christian PohlDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Sven WellmannDepartment of Neonatology, University Children's Hospital Basel UKBB, University of Basel, Basel, Switzerland.
Boris MetzeDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ann-Katrin BurdenskyDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Vinzenz BoosDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-6895-4861
Payman BarikbinDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christoph BührerDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Christoph CzernikDepartment of Neonatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEUniversity of Basel · CHKlinikum im Friedrichshain · DESpital Zollikerberg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the prognostic value of early echocardiographic indices of right ventricular function and vasoactive peptides for prediction of bronchopulmonary dysplasia (BPD) or death in very preterm infants.

methodsProspective study involving 294 very preterm infants (median [IQR] gestational age 28.4 [26.4-30.4] weeks, birth weight 1065 [800-1380] g), of whom 57 developed BPD (oxygen supplementation at 36 weeks postmenstrual age) and 10 died. Tricuspid annular plane systolic excursion (TAPSE), right ventricular index of myocardial performance (RIMP), plasma concentrations of mid-regional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) were measured on day 7 of life.

resultsRIMP was significantly increased (median [IQR] 0.3 [0.23-0.38] vs 0.22 [0.15-0.29]), TAPSE decreased (median [IQR] 5.0 [5.0-6.0] vs 6.0 [5.4-7.0] mm), MR-proANP increased (median [IQR] 784 [540-936] vs 353 [247-625] pmol/L), and CT-proET1 increased (median [IQR] 249 [190-345] vs 199 [158-284] pmol/L) in infants who developed BPD or died, as compared to controls. All variables showed significant but weak correlations with each other (rS -0.182 to 0.359) and predicted BPD/death with similar accuracy (areas under receiver operator characteristic curves 0.62 to 0.77). Multiple regression revealed only RIMP and birth weight as independent predictors of BPD or death.

conclusionsVasoactive peptide concentrations and echocardiographic assessment employing standardized measures, notably RIMP, on day 7 of life are useful to identify preterm infants at increased risk for BPD or death.

Indexed as

Area Under CurveAtrial Natriuretic FactorBronchopulmonary DysplasiaEchocardiographyEndothelin-1FemaleGestational AgeHumansInfant, NewbornInfant, PrematureInfant, Very Low Birth WeightMaleProspective StudiesROC CurveUp-RegulationVentricular Function, RightAtrial Natriuretic FactorEndothelin-1

Identifiers

PMID34550991
PMCPMC8457497
OpenAlexW3200926934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.